Compare $ABVC vs $KYNB | Chartloom

Compare

$ABVC vs $KYNB

ABVC Biopharma Inc · Kyntra Bio Inc

ABVC

ABVC Biopharma Inc

KYNB

Kyntra Bio Inc

Compare $ABVC vs $KYNB

Comparing ABVC Biopharma Inc and Kyntra Bio Inc

ABVCABVC Biopharma Inc

KYNBKyntra Bio Inc

ABVCABVC Biopharma Inc

Market cap

$26M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-100.0%

YTD performance

-54.3%

52W performance

-69.1%

FCF yield

-10.4%

KYNBKyntra Bio Inc

Market cap

$25M

P/E (TTM)

0.14x

Forward P/E (NTM)

—

Forward P/S (NTM)

3.52x

Rev growth (TTM)

-91.4%

YTD performance

-33.3%

52W performance

-46.4%

FCF yield

-153.8%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ABVC

KYNB

Detailed metrics comparison

ABVC

ABVC Biopharma Inc

KYNB

Kyntra Bio Inc

Market Cap

ABVC$26M

KYNB$25M

Enterprise Value

ABVC$27M

KYNB$-26M

Price

ABVC$1.00

KYNB$6.11

P/E Ratio

ABVCN/A

KYNB0.14x

P/S Ratio

ABVC39.44x

KYNB5.36x

EV/Sales

ABVC40.47x

KYNB-5.61x

EV/EBITDA

ABVC0.00x

KYNB0.00x

P/B Ratio

ABVC3.06x

KYNB0.97x

P/FCF Ratio

ABVCN/A

KYNBN/A

EV/FCF

ABVC-9.95x

KYNB0.68x

PEG Ratio

ABVCN/A

KYNBN/A

Forward P/E (NTM)

ABVCN/A

KYNBN/A

Forward P/S (NTM)

ABVCN/A

KYNB3.52x

Revenue (TTM)

ABVC$0

KYNB$5M

Revenue Growth (YoY)

ABVC-100.0%

KYNB-91.4%

Forward Rev Growth

ABVC0.0%

KYNB21.6%

Gross Margin (TTM)

ABVC0.3%

KYNB6.3%

Operating Margin (TTM)

ABVC0.0%

KYNB0.0%

EBITDA Margin (TTM)

ABVC0.0%

KYNB-1083.7%

Net Margin (TTM)

ABVC0.0%

KYNB3967.8%

FCF Margin (TTM)

ABVCN/A

KYNB-824.4%

Net Income (TTM)

ABVC$-8M

KYNB$183M

FCF (TTM)

ABVC$-3M

KYNB$-38M

EPS (TTM)

ABVC-$0.30

KYNB$45.25

ROE (TTM)

ABVC-7147.0%

KYNB-29091.0%

ROA (TTM)

ABVC-3883.0%

KYNB156.8%

ROIC (TTM)

ABVC-6509.0%

KYNB-25645.0%

Cash

ABVC$32K

KYNB$51M

Debt

ABVC$859K

KYNB$0

Net Cash/Debt

ABVC$-827K

KYNB$51M

Current Ratio (TTM)

ABVC0.07x

KYNB2.69x

Quick Ratio (TTM)

ABVC0.05x

KYNB2.57x

Debt/Equity (TTM)

ABVC0.08x

KYNB0.59x

Debt/Assets (TTM)

ABVC0.0%

KYNB0.0%

Interest Coverage (TTM)

ABVCN/A

KYNBN/A

Net Debt/EBITDA (TTM)

ABVC0.00x

KYNB0.00x

Beta

ABVC0.50

KYNB1.07

52W Performance

ABVC-69.1%

KYNB-46.4%

YTD Performance

ABVC-54.3%

KYNB-33.3%

% from 52W High

ABVC-70.0%

KYNB-47.6%

% from 52W Low

ABVC40.8%

KYNB8.7%

Asset Turnover (TTM)

ABVC0.06x

KYNB0.05x

FCF Yield (TTM)

ABVC-10.4%

KYNB-153.8%

Earnings Yield (TTM)

ABVC-30.4%

KYNB740.3%

Dividend Yield (TTM)

ABVCN/A

KYNBN/A

Rule of 40

ABVC-100.0

KYNB-915.8

EV/GP/RG

ABVCN/A

KYNBN/A

Ticker research

View ABVC research View KYNB research

Metric	ABVC ABVC Biopharma Inc	KYNB Kyntra Bio Inc
Market & Valuation
Market Cap	$26M	$25M
Enterprise Value	$27M	$-26M
Price	$1.00	$6.11
P/E Ratio	N/A	0.14x
P/S Ratio	39.44x	5.36x
EV/Sales	40.47x	-5.61x
EV/EBITDA	0.00x	0.00x
P/B Ratio	3.06x	0.97x
P/FCF Ratio	N/A	N/A
EV/FCF	-9.95x	0.68x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	3.52x
Revenue & Growth
Revenue (TTM)	$0	$5M
Revenue Growth (YoY)	-100.0%	-91.4%
Forward Rev Growth	0.0%	21.6%
Profitability
Gross Margin (TTM)	0.3%	6.3%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-1083.7%
Net Margin (TTM)	0.0%	3967.8%
FCF Margin (TTM)	N/A	-824.4%
Net Income (TTM)	$-8M	$183M
FCF (TTM)	$-3M	$-38M
EPS (TTM)	-$0.30	$45.25
ROE (TTM)	-7147.0%	-29091.0%
ROA (TTM)	-3883.0%	156.8%
ROIC (TTM)	-6509.0%	-25645.0%
Financial Health
Cash	$32K	$51M
Debt	$859K	$0
Net Cash/Debt	$-827K	$51M
Current Ratio (TTM)	0.07x	2.69x
Quick Ratio (TTM)	0.05x	2.57x
Debt/Equity (TTM)	0.08x	0.59x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.50	1.07
52W Performance	-69.1%	-46.4%
YTD Performance	-54.3%	-33.3%
% from 52W High	-70.0%	-47.6%
% from 52W Low	40.8%	8.7%
Efficiency & Yields
Asset Turnover (TTM)	0.06x	0.05x
FCF Yield (TTM)	-10.4%	-153.8%
Earnings Yield (TTM)	-30.4%	740.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-100.0	-915.8
EV/GP/RG	N/A	N/A
Ticker research	View ABVC research	View KYNB research

Valuation

P/E Ratio

KYNB

0.14x

P/S Ratio

KYNB

5.36x

ABVC

39.44x

EV/FCF

ABVC

-9.95x

KYNB

0.68x

Growth & revenue

Revenue Growth TTM

KYNB

-91.4%

ABVC

-100.0%

Forward Revenue Growth

KYNB

21.6%

ABVC

0.0%

Profitability & performance

Gross Margin

KYNB

6.3%

ABVC

0.3%

ROE

ABVC

-7147.0%

KYNB

-29091.0%

FCF Yield %

ABVC

-10.4%

KYNB

-153.8%

52-Week Performance

KYNB

-46.4%

ABVC

-69.1%

Detailed metrics comparison

ABVC

ABVC Biopharma Inc

KYNB

Kyntra Bio Inc

Market Cap

ABVC$26M

KYNB$25M

Enterprise Value

ABVC$27M

KYNB$-26M

Price

ABVC$1.00

KYNB$6.11

P/E Ratio

ABVCN/A

KYNB0.14x

P/S Ratio

ABVC39.44x

KYNB5.36x

EV/Sales

ABVC40.47x

KYNB-5.61x

EV/EBITDA

ABVC0.00x

KYNB0.00x

P/B Ratio

ABVC3.06x

KYNB0.97x

P/FCF Ratio

ABVCN/A

KYNBN/A

EV/FCF

ABVC-9.95x

KYNB0.68x

PEG Ratio

ABVCN/A

KYNBN/A

Forward P/E (NTM)

ABVCN/A

KYNBN/A

Forward P/S (NTM)

ABVCN/A

KYNB3.52x

Revenue (TTM)

ABVC$0

KYNB$5M

Revenue Growth (YoY)

ABVC-100.0%

KYNB-91.4%

Forward Rev Growth

ABVC0.0%

KYNB21.6%

Gross Margin (TTM)

ABVC0.3%

KYNB6.3%

Operating Margin (TTM)

ABVC0.0%

KYNB0.0%

EBITDA Margin (TTM)

ABVC0.0%

KYNB-1083.7%

Net Margin (TTM)

ABVC0.0%

KYNB3967.8%

FCF Margin (TTM)

ABVCN/A

KYNB-824.4%

Net Income (TTM)

ABVC$-8M

KYNB$183M

FCF (TTM)

ABVC$-3M

KYNB$-38M

EPS (TTM)

ABVC-$0.30

KYNB$45.25

ROE (TTM)

ABVC-7147.0%

KYNB-29091.0%

ROA (TTM)

ABVC-3883.0%

KYNB156.8%

ROIC (TTM)

ABVC-6509.0%

KYNB-25645.0%

Cash

ABVC$32K

KYNB$51M

Debt

ABVC$859K

KYNB$0

Net Cash/Debt

ABVC$-827K

KYNB$51M

Current Ratio (TTM)

ABVC0.07x

KYNB2.69x

Quick Ratio (TTM)

ABVC0.05x

KYNB2.57x

Debt/Equity (TTM)

ABVC0.08x

KYNB0.59x

Debt/Assets (TTM)

ABVC0.0%

KYNB0.0%

Interest Coverage (TTM)

ABVCN/A

KYNBN/A

Net Debt/EBITDA (TTM)

ABVC0.00x

KYNB0.00x

Beta

ABVC0.50

KYNB1.07

52W Performance

ABVC-69.1%

KYNB-46.4%

YTD Performance

ABVC-54.3%

KYNB-33.3%

% from 52W High

ABVC-70.0%

KYNB-47.6%

% from 52W Low

ABVC40.8%

KYNB8.7%

Asset Turnover (TTM)

ABVC0.06x

KYNB0.05x

FCF Yield (TTM)

ABVC-10.4%

KYNB-153.8%

Earnings Yield (TTM)

ABVC-30.4%

KYNB740.3%

Dividend Yield (TTM)

ABVCN/A

KYNBN/A

Rule of 40

ABVC-100.0

KYNB-915.8

EV/GP/RG

ABVCN/A

KYNBN/A

Ticker research

View ABVC research View KYNB research

Metric	ABVC ABVC Biopharma Inc	KYNB Kyntra Bio Inc
Market & Valuation
Market Cap	$26M	$25M
Enterprise Value	$27M	$-26M
Price	$1.00	$6.11
P/E Ratio	N/A	0.14x
P/S Ratio	39.44x	5.36x
EV/Sales	40.47x	-5.61x
EV/EBITDA	0.00x	0.00x
P/B Ratio	3.06x	0.97x
P/FCF Ratio	N/A	N/A
EV/FCF	-9.95x	0.68x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	3.52x
Revenue & Growth
Revenue (TTM)	$0	$5M
Revenue Growth (YoY)	-100.0%	-91.4%
Forward Rev Growth	0.0%	21.6%
Profitability
Gross Margin (TTM)	0.3%	6.3%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-1083.7%
Net Margin (TTM)	0.0%	3967.8%
FCF Margin (TTM)	N/A	-824.4%
Net Income (TTM)	$-8M	$183M
FCF (TTM)	$-3M	$-38M
EPS (TTM)	-$0.30	$45.25
ROE (TTM)	-7147.0%	-29091.0%
ROA (TTM)	-3883.0%	156.8%
ROIC (TTM)	-6509.0%	-25645.0%
Financial Health
Cash	$32K	$51M
Debt	$859K	$0
Net Cash/Debt	$-827K	$51M
Current Ratio (TTM)	0.07x	2.69x
Quick Ratio (TTM)	0.05x	2.57x
Debt/Equity (TTM)	0.08x	0.59x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.50	1.07
52W Performance	-69.1%	-46.4%
YTD Performance	-54.3%	-33.3%
% from 52W High	-70.0%	-47.6%
% from 52W Low	40.8%	8.7%
Efficiency & Yields
Asset Turnover (TTM)	0.06x	0.05x
FCF Yield (TTM)	-10.4%	-153.8%
Earnings Yield (TTM)	-30.4%	740.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-100.0	-915.8
EV/GP/RG	N/A	N/A
Ticker research	View ABVC research	View KYNB research